China Biologic Products, Inc. (CBPO) Reports Q3 EPS of $0.54, Updated Outlook

November 8, 2012 5:37 PM EST
Get Alerts CBPO Hot Sheet
Trade CBPO Now!
Join SI Premium – FREE
China Biologic Products, Inc. (NASDAQ: CBPO) reported Q3 EPS of $0.54, versus $0.42 reported last year. Revenue for the quarter came in at $53.1 million, versus $41.3 million reported last year.


For the full year of 2012, the Company now expects sales to reach or surpass the high end of previous guidance of $176 million, representing mid-to-high-teens annual growth. The Company estimates full year non-GAAP adjusted net income to be in the range of $46 million to $48 million, compared to the previous guidance range of $38 million to $40 million.

For earnings history and earnings-related data on China Biologic Products, Inc. (CBPO) click here.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Earnings, Guidance

Related Entities


Add Your Comment